Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin During and After Physical Exercise in T1DM
NCT04049110Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Aug 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in type 1 diabetes mellitus (T1D), sponsored by Insel Gruppe. Started Aug 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04049110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049110.